First preclinical support for the 'danger theory' in inhibitor development
Haemophilia
.
2016 Sep;22(5):654-6.
doi: 10.1111/hae.13042.
Epub 2016 Jul 25.
Authors
L F D van Vulpen
1
2
,
S C Mastbergen
3
,
R E G Schutgens
4
Affiliations
1
Van Creveldkliniek, University Medical Center Utrecht, Utrecht, the Netherlands.
[email protected]
.
2
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
[email protected]
.
3
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
4
Van Creveldkliniek, University Medical Center Utrecht, Utrecht, the Netherlands.
PMID:
27457662
DOI:
10.1111/hae.13042
No abstract available